Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Safety and Immunogenicity Among Different Age-groups Receiving Different Split Influenza Vaccines

NCT01654809 is registered in ClinicalTrials.gov with Beijing Center for Disease Control and Prevention as lead sponsor.

NCT NCT01654809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01654809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Safety and Immunogenicity Among Different Age-groups Receiving Different Split Influenza Vaccines
Lead sponsor
Beijing Center for Disease Control and Prevention
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2010
Completion date
June 30, 2011
Enrollment
900 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

influenza